上海疾控中心与辉瑞中国签合作协议 建设疫苗临床试验基地
上海市疾病预防控制中心和辉瑞中国在上海共同签署了战略合作协议,双方将开展公共卫生人才梯队、疫苗临床试验基地、疾控机构形象建设等三方面的合作,具体包括设立疾控系统人才培养项目,夯实疾控系统人员专业技能,打造多层次、多学科人才梯队;双方将携手建设上海疫苗临床试验基地,完善上海疫苗评价管理体系。
此外,双方还将继续开展对公众疾病知识的科普宣传和教育,为疾控工作营造良好的外部支持环境。(ta/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.